Tendinopathy and its treatment with platelet-rich plasma (PRP)

Histology and Histopathology

Volumn 28, Issue 12, 2013, Pages 1537-1546

  Jiang, Dapeng ^a   Wang, James H C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Platelet rich plasma; Tendinopathy; Tendon stem cells; Tenocytes

Indexed keywords

ANIMAL; HUMAN; PATHOPHYSIOLOGY; REVIEW; TENDINITIS; THROMBOCYTE RICH PLASMA;

ANIMALS; HUMANS; PLATELET-RICH PLASMA; TENDINOPATHY;

EID: 84888116448     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. Ahmed I.M., Lagopoulos M., McConnell P., Soames R.W. and Sefton G.K. (1998). Blood supply of the Achilles tendon. J. Orthop. Res. 16, 591-596.
2. Alfredson H. and Lorentzon R. (2002). Chronic tendon pain: no signs of chemical inflammation but high concentrations of the neurotransmitter glutamate. Implications for treatment? Curr. Drug Targets 3, 43-54.
3. Almekinders L.C., Vellema J.H. and Weinhold P.S. (2002). Strain patterns in the patellar tendon and the implications for patellar tendinopathy. Knee Surg. Sports Traumatol. Arthrosc. 10, 2-5.
4. Almekinders L.C., Weinhold P.S. and Maffulli N. (2003). Compression etiology in tendinopathy. Clin. Sports Med. 22, 703-710.
5. Amiel D., Frank C., Harwood F., Fronek J. and Akeson W. (1984). Tendons and ligaments: a morphological and biochemical comparison. J. Orthop. Res. 1, 257-265.
6. Andersson G., Danielson P., Alfredson H. and Forsgren S. (2008). Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon. Regul. Pept. 150, 81-87.
7. Andia I., Sanchez M. and Maffulli N. (2010). Tendon healing and platelet-rich plasma therapies. Expert Opin. Biol. Ther. 10, 1415-1426.
8. Archambault J.M., Jelinsky S.A., Lake S.P., Hill A.A., Glaser D.L. and Soslowsky L.J. (2007). Rat supraspinatus tendon expresses cartilage markers with overuse. J. Orthop. Res. 25, 617-624.
9. Asfaha S., Cenac N., Houle S., Altier C., Papez M.D., Nguyen C., Steinhoff M., Chapman K., Zamponi G.W. and Vergnolle N. (2007). Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br. J. Pharmacol. 150, 176-185.
10. Backman L.J., Andersson G., Wennstig G., Forsgren S. and Danielson P. (2011). Endogenous substance P production in the Achilles tendon increases with loading in an in vivo model of tendinopathypeptidergic elevation preceding tendinosis-like tissue changes. J. Musculoskelet. Neuronal Interact. 11, 133-140.
11. Barbe M.F., Barr A.E., Gorzelany I., Amin M., Gaughan J.P. and Safadi F.F. (2003). Chronic repetitive reaching and grasping results in decreased motor performance and widespread tissue responses in a rat model of MSD. J. Orthop. Res. 21, 167-176.
12. Batten M.L., Hansen J.C. and Dahners L.E. (1996). Influence of dosage and timing of application of platelet-derived growth factor on early healing of the rat medial collateral ligament. J. Orthop. Res. 14, 736-741.
13. Bendinelli P., Matteucci E., Dogliotti G., Corsi M.M., Banfi G., Maroni P. and Desiderio M.A. (2010). Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappaB inhibition via HGF. J. Cell. Physiol. 225, 757-766.
14. Bi Y., Ehirchiou D., Kilts T.M., Inkson C.A., Embree M.C., Sonoyama W., Li L., Leet A.I., Seo B.M., Zhang L., Shi S. and Young M.F. (2007). Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat. Med. 13, 1219-1227.
15. Birch H.L., Rutter G.A. and Goodship A.E. (1997). Oxidative energy metabolism in equine tendon cells. Res. Vet. Sci. 62, 93-97.
16. Birch H.L., Bailey A.J. and Goodship A.E. (1998). Macroscopic 'degeneration' of equine superficial digital flexor tendon is accompanied by a change in extracellular matrix composition. Equine Vet. J. 30, 534-539.
17. Bjur D., Danielson P., Alfredson H. and Forsgren S. (2008a). Immunohistochemical and in situ hybridization observations favor a local catecholamine production in the human Achilles tendon. Histol. Histopathol. 23, 197-208.
18. Bjur D., Danielson P., Alfredson H. and Forsgren S. (2008b). Presence of a non-neuronal cholinergic system and occurrence of up-and down-regulation in expression of M2 muscarinic acetylcholine receptors: new aspects of importance regarding Achilles tendon tendinosis (tendinopathy). Cell Tissue Res. 331, 385-400.
19. Buck F.M., Grehn H., Hilbe M., Pfirrmann C.W., Manzanell S. and Hodler J. (2009). Degeneration of the long biceps tendon: comparison of MRI with gross anatomy and histology. Am. J. Roentgenol. 193, 1367-1375.
20. Burssens P., Steyaert A., Forsyth R., van Ovost E.J., Depaepe Y. and Verdonk R. (2005). Exogenously administered substance P and neutral endopeptidase inhibitors stimulate fibroblast proliferation, angiogenesis and collagen organization during Achilles tendon healing. Foot Ankle Int. 26, 832-839.
21. Butler D.L., Grood E.S., Noyes F.R. and Zernicke R.F. (1978). Biomechanics of ligaments and tendons. Exerc. Sport Sci. Rev. 6, 125-181.
22. Cetti R., Junge J. and Vyberg M. (2003). Spontaneous rupture of the Achilles tendon is preceded by widespread and bilateral tendon damage and ipsilateral inflammation: a clinical and histopathologic study of 60 patients. Acta Orthop. Scand. 74, 78-84.
23. Chaudhury S., de La Lama M., Adler R.S., Gulotta L.V., Skonieczki B., Chang A., Moley P., Cordasco F., Hannafin J. and Fealy S. (2013). Platelet-rich plasma for the treatment of lateral epicondylitis: sonographic assessment of tendon morphology and vascularity (pilot study). Skeletal Radiol. 42:91-97.
24. Cofield R.H. (1985). Rotator cuff disease of the shoulder. J. Bone Joint Surg. Am. 67, 974-979.
25. Cook J.L., Khan K.M., Kiss Z.S. and Griffiths L. (2000). Patellar tendinopathy in junior basketball players: a controlled clinical and ultrasonographic study of 268 patellar tendons in players aged 14-18 years. Scand. J. Med. Sci. Sports 10, 216-220.
26. Danielson P. (2009). Reviving the "biochemical" hypothesis for tendinopathy: new findings suggest the involvement of locally produced signal substances. Br. J. Sports Med. 43, 265-268.
27. de Almeida A.M., Demange M.K., Sobrado M.F., Rodrigues M.B., Pedrinelli A. and Hernandez A.J. (2012). Patellar tendon healing with platelet-rich plasma: a prospective randomized controlled trial. Am. J. Sports Med. 40, 1282-1288.
28. de Jonge S., de Vos R.J., Van Schie H.T., Verhaar J.A., Weir A. and Tol J.L. (2010). One-year follow-up of a randomised controlled trial on added splinting to eccentric exercises in chronic midportion Achilles tendinopathy. Br. J. Sports Med. 44, 673-677.
29. de Jonge S., de Vos R.J., Weir A., van Schie H.T., Bierma-Zeinstra S.M., Verhaar J.A., Weinans H. and Tol J.L. (2011). One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am. J. Sports Med. 39, 1623-1629.
30. de Mos M., van der Windt, A.E., Jahr H., van Schie H.T., Weinans H., Verhaar J.A. and van Osch G.J. (2008). Can platelet-rich plasma enhance tendon repair? A cell culture study. Am. J. Sports Med. 36, 1171-1178.
31. de Vos R.J., van Veldhoven P.L., Moen M.H., Weir A., Tol J.L. and Maffulli N. (2010a). Autologous growth factor injections in chronic tendinopathy: a systematic review. Br. Med. Bull. 95, 63-77.
32. de Vos R.J., Weir A., van Schie H.T., Bierma-Zeinstra S.M., Verhaar J.A., Weinans H. and Tol J.L. (2010b). Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA 303, 144-149.
33. de Vos R.J., Weir A., Tol J.L., Verhaar J.A., Weinans H. and van Schie H.T. (2011). No effects of PRP on ultrasonographic tendon structure and neovascularisation in chronic midportion Achilles tendinopathy. Br. J. Sports Med. 45, 387-392.
34. Del Buono A., Papalia R., Denaro V., Maccauro G. and Maffulli N. (2011). Platelet rich plasma and tendinopathy: state of the art. Int. J. Immunopathol. Pharmacol. 24, 79-83.
35. Denzlinger C. (1996). Biology and pathophysiology of leukotrienes. Crit. Rev. Oncol. Hematol. 23, 167-223.
36. Diegelmann R.F. and Evans M.C. (2004). Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci. 9, 283-289.
37. Dragoo J.L., Braun H.J., Durham J.L., Ridley B.A., Odegaard J.I., Luong R. and Arnoczky S.P. (2012). Comparison of the acute inflammatory response of twocommercial platelet-rich plasma systems in healthy rabbit tendons. Am. J. Sports Med. 40, 1274-1281.
38. El-Sharkawy H., Kantarci A., Deady J., Hasturk H., Liu H., Alshahat M. and Van Dyke T.E. (2007). Platelet-rich plasma: growth factors and pro-and anti-inflammatory properties. J. Periodontol. 78, 661-669.
39. Engebretsen L., Steffen K., Alsousou J., Anitua E., Bachl N., Devilee R., Everts P., Hamilton B., Huard J., Jenoure P., Kelberine F., Kon E., Maffulli N., Matheson G., Mei-Dan O., Menetrey J., Philippon M., Randelli P., Schamasch P., Schwellnus M., Vernec A. and Verrall G. (2010). IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br. J. Sports Med. 44, 1072-1081.
40. Fenwick S.A., Hazleman B.L. and Riley G.P. (2002). The vasculature and its role in the damaged and healing tendon. Arthritis Res. 4, 252-260.
41. Ferry S.T., Dahners L.E., Afshari H.M. and Weinhold P.S. (2007). The effects of common anti-inflammatory drugs on the healing rat patellar tendon. Am. J. Sports Med. 35, 1326-1333.
42. Filardo G., Kon E., Della Villa S., Vincentelli F., Fornasari P.M. and Marcacci M. (2010). Use of platelet-rich plasma for the treatment of refractory jumper's knee. Int. Orthop. 34, 909-915.
43. Foster T.E., Puskas B.L., Mandelbaum B.R., Gerhardt M.B. and Rodeo S.A. (2009). Platelet-rich plasma: from basic science to clinical applications. Am. J. Sports Med. 37, 2259-2272.
44. Frey C., Shereff M. and Greenidge N. (1990). Vascularity of the posterior tibial tendon. J. Bone Joint Surg. Am. 72, 884-888.
45. Fridman R., Cain J.D., Weil L. Jr and Weil L. Sr (2008). Extracorporeal shockwave therapy for the treatment of Achilles tendinopathies: a prospective study. J. Am. Podiatr. Med. Assoc. 98, 466-468.
46. Fu S.C., Wang W., Pau H.M., Wong Y.P., Chan K.M. and Rolf C.G. (2002). Increased expression of transforming growth factor-beta1 in patellar tendinosis. Clin. Orthop. Relat. Res. 174-183.
47. Gaweda K., Tarczynska M. and Krzyzanowski W. (2010). Treatment of Achilles tendinopathy with platelet-rich plasma. Int. J. Sports Med. 31, 577-583.
48. Gosens T., Peerbooms J.C., van Laar W. and den Oudsten B.L. (2011). Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am. J. Sports Med. 39, 1200-1208.
49. Harrison S., Vavken P., Kevy S., Jacobson M., Zurakowski D. and Murray M.M. (2011). Platelet activation by collagen provides sustained release of anabolic cytokines. Am. J. Sports Med. 39, 729-734.
50. Hsu C. and Chang J. (2004). Clinical implications of growth factors in flexor tendon wound healing. J. Hand Surg. Am. 29, 551-563.
51. Jones G.C., Corps A.N., Pennington C.J., Clark I.M., Edwards D.R., Bradley M.M., Hazleman, B.L. and Riley, G.P. (2006). Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum. 54, 832-842.
52. Kannus P. and Jozsa L. (1991). Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J. Bone Joint Surg. Am. 73, 1507-1525.
53. Ker R.F. (1981). Dynamic tensile properties of the plantaris tendon of sheep (Ovis aries). J. Exp. Biol. 93, 283-302.
54. Khan K.M., Cook J.L., Bonar F., Harcourt P. and Astrom M. (1999). Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med. 27, 393-408.
55. Khan K.M., Cook J.L., Kannus P., Maffulli N. and Bonar S.F. (2002). Time to abandon the "tendinitis" myth. BMJ 324, 626-627.
56. Khan M.H., Li Z. and Wang J.H. (2005). Repeated exposure of tendon to prostaglandin-E2 leads to localized tendon degeneration. Clin. J. Sport Med. 15, 27-33.
57. Knobloch K., Yoon U. and Vogt P.M. (2008). Acute and overuse injuries correlated to hours of training in master running athletes. Foot Ankle Int. 29, 671-676.
58. Kon E., Filardo G., Delcogliano M., Presti M.L., Russo A., Bondi A., Di Martino A., Cenacchi A., Fornasari P.M. and Marcacci M. (2009). Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. Injury 40, 598-603.
59. Kon E., Filardo G., Di Martino A. and Marcacci M. (2011). Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg. Sports Traumatol. Arthrosc. 19, 516-527.
60. Krapf D., Kaipel M. and Majewski M. (2012). Structural and biomechanical characteristics after early mobilization in an achilles tendon rupture model: operative versus nonoperative treatment. Orthopedics 35, e1383-1388.
61. Kujala U.M., Jarvinen M., Natri A., Lehto M., Nelimarkka O., Hurme M., Virta L. and Finne, J. (1992). ABO blood groups and musculoskeletal injuries. Injury 23, 131-133.
62. Lavagnino, M. and Arnoczky, S.P. (2005). In vitro alterations in cytoskeletal tensional homeostasis control gene expression in tendon cells. J. Orthop. Res. 23, 1211-1218.
63. Lavagnino M., Arnoczky S.P., Frank K. and Tian T. (2005). Collagen fibril diameter distribution does not reflect changes in the mechanical properties of in vitro stress-deprived tendons. J. Biomech. 38, 69-75.
64. Lavagnino M., Arnoczky S.P., Egerbacher M., Gardner K.L. and Burns M.E. (2006). Isolated fibrillar damage in tendons stimulates local collagenase mRNA expression and protein synthesis. J. Biomech. 39, 2355-2362.
65. Li Z., Yang G., Khan M., Stone D., Woo S.L. and Wang J.H. (2004). Inflammatory response of human tendon fibroblasts to cyclic mechanical stretching. Am. J. Sports Med. 32, 435-440.
66. Lian O., Dahl J., Ackermann P.W., Frihagen F., Engebretsen L. and Bahr R. (2006). Pronociceptive and antinociceptive neuromediators in patellar tendinopathy. Am. J. Sports Med. 34, 1801-1808.
67. Longo U.G., Ronga M. and Maffulli N. (2009). Achilles tendinopathy. Sports Med. Arthrosc. 17, 112-126.
68. Lyman J., Weinhold P.S. and Almekinders L.C. (2004). Strain behavior of the distal achilles tendon: implications for insertional achilles tendinopathy. Am. J. Sports Med. 32, 457-461.
69. Maffulli N. and Kader D. (2002). Tendinopathy of tendo achillis. J. Bone Joint Surg. Br. 84, 1-8.
70. Maffulli N. and Longo U.G. (2008a). Conservative management for tendinopathy: is there enough scientific evidence? Rheumatology (Oxford) 47, 390-391.
71. Maffulli N. and Longo U.G. (2008b). How do eccentric exercises work in tendinopathy? Rheumatology (Oxford) 47, 1444-1445.
72. Maffulli N., Ewen S.W., Waterston S.W., Reaper J. and Barrass V. (2000). Tenocytes from ruptured and tendinopathic achilles tendons produce greater quantities of type III collagen than tenocytes from normal achilles tendons. An in vitro model of human tendon healing. Am. J. Sports Med. 28, 499-505.
73. Martin P. and Leibovich S.J. (2005). Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 15, 599-607.
74. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E. and Georgeff K.R. (1998). Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 85, 638-646.
75. McCarrel T. and Fortier L. (2009). Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J. Orthop. Res. 27, 1033-1042.
76. Mienaltowski M.J., Adams S.M. and Birk D.E. (2013). Regional differences in stem cell/progenitor cell populations from the mouse achilles tendon. Tissue Eng. Part A. 19, 199-210.
77. Mishra A. and Pavelko T. (2006). Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am. J. Sports Med. 34, 1774-1778.
78. Mokone G.G., Gajjar M., September A.V., Schwellnus M.P., Greenberg J., Noakes T.D. and Collins M. (2005). The guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with achilles tendon injuries. Am. J. Sports Med. 33, 1016-1021.
79. Mokone G.G., Schwellnus M.P., Noakes T.D. and Collins M. (2006). The COL5A1 gene and Achilles tendon pathology. Scand. J. Med. Sci. Sports 16, 19-26.
80. Molloy T., Wang Y. and Murrell G. (2003). The roles of growth factors in tendon and ligament healing. Sports Med. 33, 381-394.
81. Monto R.R. (2012). Platelet rich plasma treatment for chronic Achilles tendinosis. Foot Ankle Int. 33, 379-385.
82. Nakama L.H., King K.B., Abrahamsson S. and Rempel D.M. (2005). Evidence of tendon microtears due to cyclical loading in an in vivo tendinopathy model. J. Orthop. Res. 23, 1199-1205.
83. Park Y.G., Han S.B., Song S.J., Kim T.J. and Ha C.W. (2012). Plateletrich plasma therapy for knee joint problems: review of the literature, current practice and legal perspectives in Korea. Knee Surg. Relat. Res. 24, 70-78.
84. Pearce C.J., Ismail M. and Calder J.D. (2009). Is apoptosis the cause of noninsertional achilles tendinopathy? Am. J. Sports Med. 37, 2440-2444.
85. Pietramaggiori G., Scherer S.S., Mathews J.C., Gennaoui T., Lancerotto L., Ragno G., Valeri, C.R. and Orgill, D.P. (2010). Quiescent platelets stimulate angiogenesis and diabetic wound repair. J. Surg. Res. 160, 169-177.
86. Riley G. (2004). The pathogenesis of tendinopathy. A molecular perspective. Rheumatology (Oxford) 43, 131-142.
87. Riley G.P. (2005). Gene expression and matrix turnover in overused and damaged tendons. Scand. J. Med. Sci. Sports 15, 241-251.
88. Rui Y.F., Lui P.P., Li G., Fu S.C., Lee Y.W. and Chan K.M. (2010). Isolation and characterization of multipotent rat tendon-derived stem cells. Tissue Eng. Part A 16, 1549-1558.
89. Sadoghi P., Rosso C., Valderrabano V., Leithner A. and Vavken P. (2013). The role of platelets in the treatment of Achilles tendon injuries. J. Orthop. Res. 31, 111-118.
90. Sanchez, M., Anitua E., Azofra J., Andia I., Padilla S. and Mujika I. (2007). Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am. J. Sports Med. 35, 245-251.
91. Schnabel L.V., Mohammed H.O., Miller B.J., McDermott W.G., Jacobson M.S., Santangelo K.S. and Fortier L.A. (2007). Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J. Orthop. Res. 25, 230-240.
92. Schofer M.D., Hinrichs F., Peterlein C.D., Arendt M. and Schmitt J. (2009). High-versus low-energy extracorporeal shock wave therapy of rotator cuff tendinopathy: a prospective, randomised, controlled study. Acta Orthop. Belg. 75, 452-458.
93. Schubert T.E., Weidler C., Lerch K., Hofstadter F. and Straub R.H. (2005). Achilles tendinosis is associated with sprouting of substance P positive nerve fibres. Ann. Rheum. Dis. 64, 1083-1086.
94. Scott A., Khan K.M., Heer J., Cook J.L., Lian O. and Duronio V. (2005). High strain mechanical loading rapidly induces tendon apoptosis: an ex vivo rat tibialis anterior model. Br. J. Sports Med. 39, e25.
95. Scott A., Cook J.L., Hart D.A., Walker D.C., Duronio V. and Khan K.M. (2007). Tenocyte responses to mechanical loading in vivo: a role for local insulin-like growth factor 1 signaling in early tendinosis in rats. Arthritis Rheum. 56, 871-881.
96. Scott A., Alfredson H. and Forsgren S. (2008). VGluT2 expression in painful Achilles and patellar tendinosis: evidence of local glutamate release by tenocytes. J. Orthop. Res. 26, 685-692.
97. Shi Y., Fu Y., Tong W., Geng Y., Lui P.P., Tang T., Zhang X. and Dai K. (2012). Uniaxial mechanical tension promoted osteogenic differentiation of rat tendon-derived stem cells (rTDSCs) via the Wnt5a-RhoA pathway. J. Cell. Biochem. 113, 3133-3142.
98. Silva R.D., Glazebrook M.A., Campos V.C. and Vasconcelos A.C. (2011). Achilles tendinosis: a morphometrical study in a rat model. Int. J. Clin. Exp. Pathol. 4, 683-691.
99. Skutek M., van Griensven M., Zeichen J., Brauer N. and Bosch U. (2003). Cyclic mechanical stretching of human patellar tendon fibroblasts: activation of JNK and modulation of apoptosis. Knee Surg. Sports Traumatol. Arthrosc. 11, 122-129.
100. Sundman E.A., Cole B.J. and Fortier L.A. (2011). Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am. J. Sports Med. 39, 2135-2140.
101. van Buul G.M., Koevoet W.L., Kops N., Bos P.K., Verhaar J.A., Weinans H., Bernsen M.R. and van Osch G.J. (2011). Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am. J. Sports Med. 39, 2362-2370.
102. Verrall G., Schofield S. and Brustad T. (2011). Chronic Achilles tendinopathy treated with eccentric stretching program. Foot Ankle Int. 32, 843-849.
103. Wang J.H. (2006). Mechanobiology of tendon. J. Biomech. 39, 1563-1582.
104. Wang J.H., Jia F., Yang G., Yang S., Campbell B.H., Stone D. and Woo S.L. (2003). Cyclic mechanical stretching of human tendon fibroblasts increases the production of prostaglandin E2 and levels of cyclooxygenase expression: a novel in vitro model study. Connect. Tissue Res. 44, 128-133.
105. Wang J.H., Iosifidis M.I. and Fu F.H. (2006). Biomechanical basis for tendinopathy. Clin. Orthop. Relat. Res. 443, 320-332.
106. Weibrich G., Kleis W.K., Hitzler W.E. and Hafner G. (2005). Comparison of the platelet concentrate collection system with the plasma-rich-ingrowth-factors kit to produce platelet-rich plasma: a technical report. Int. J. Oral Maxillofac. Implants 20, 118-123.
107. Wolfe M.M., Lichtenstein D.R. and Singh G. (1999). Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 340, 1888-1899.
108. Wong M.E., Hollinger J.O. and Pinero G.J. (1996). Integrated processes responsible for soft tissue healing. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 82, 475-492.
109. Yuan J., Murrell G.A., Wei A.Q. and Wang M.X. (2002). Apoptosis in rotator cuff tendonopathy. J. Orthop. Res. 20, 1372-1379.
110. Zhang J. and Wang J.H. (2010a). Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet. Disord. 11, 10.
111. Zhang J. and Wang J.H. (2010b). Mechanobiological response of tendon stem cells: implications of tendon homeostasis and pathogenesis of tendinopathy. J. Orthop. Res. 28, 639-643.
112. Zhang J. and Wang J.H. (2010c). Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. Am. J. Sports Med. 38, 2477-2486.
113. Zhang J. and Wang J.H. (2010d). Production of PGE(2) increases in tendons subjected to repetitive mechanical loading and induces differentiation of tendon stem cells into non-tenocytes. J. Orthop. Res. 28, 198-203.
114. Zhang J. and Wang J.H. (2012). BMP-2 mediates PGE(2)-induced reduction of proliferation and osteogenic differentiation of human tendon stem cells. J. Orthop. Res. 30, 47-52.